Metal-free graphitic carbon nitride photocatalyst combined with bioretention and pump-and-treat technology for efficient, stable removal of nutrients and organic pollutants from urban stormwater runoff.
Urban stormwater runoff carries a complex mixture of nutrients, organic contaminants, and emerging pollutants that conventional treatment systems struggle to remove efficiently. This proposed solution combines bioretention-based heterotrophic denitrification with solar light-enabled advanced oxidation processes and pump-and-treat technology to deliver a more efficient and stable treatment approach over extended operating periods.
The core innovation is a metal-free graphitic carbon nitride (g-C3N4) photocatalyst suspended in a self-reliant photochemical reactor. By integrating biological nutrient removal with photocatalytic advanced oxidation, the system targets nitrate, phosphate, oxalate, and trace organic contaminants in a single sequential workflow.
Key features:
How it works:
Stormwater first passes through a bioretention system where heterotrophic denitrifying bacteria convert nitrate to nitrogen gas under controlled conditions. The effluent is then routed to a photochemical reactor containing suspended g-C3N4 photocatalyst, which under solar irradiation drives advanced oxidation of residual organic contaminants and further transformation of nutrients. Operational parameters are tuned to maximize removal efficiency while minimizing unwanted byproducts.
This proposal is at an early research stage. The team has prior published work demonstrating mineralization of the hormone EE2 in real hospital effluents using the same catalyst family, which supports feasibility of the photocatalytic component. However, no proof-of-concept data currently exists for the combined bioretention plus photocatalytic sequential system.
Future validation plan:
The technology readiness level is currently low (TRL 2-3), with laboratory validation of individual components underway and integrated system demonstration planned as the next milestone.
Tel Aviv University is one of Israel’s largest comprehensive public research universities with a broad academic portfolio and strong research culture. Located in Tel Aviv’s dense startup and multinational R&D corridor, it engages industry through sponsored research, shared-use facilities, executive education, and access to top talent. A dedicated technology transfer company manages IP, licensing, and venture creation, complemented by entrepreneurship programs and proof‑of‑concept support; clinical collaborations across the city’s healthcare ecosystem enable translation. Research is supported by competitive national agencies and international programs, including the Israel Innovation Authority and European research frameworks. Corporate engagement offices streamline scoping and agreements, giving partners clear entry points.